世界の物質使用障害（SUD）の治療市場：市場規模・現状・予測

• 英文タイトル：Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N8091
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、物質使用障害（SUD）の治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・物質使用障害（SUD）の治療の世界市場規模
・主要企業別市場シェア
・物質使用障害（SUD）の治療の世界市場規模：種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）
・物質使用障害（SUD）の治療の世界市場規模：用途別（病院と診療所、住居（病院以外））
・物質使用障害（SUD）の治療のアメリカ市場規模（種類別、用途別）
・物質使用障害（SUD）の治療のヨーロッパ市場規模（種類別、用途別）
・物質使用障害（SUD）の治療の中国市場規模（種類別、用途別）
・物質使用障害（SUD）の治療の日本市場規模（種類別、用途別）
・物質使用障害（SUD）の治療の東南アジア市場規模（種類別、用途別）
・物質使用障害（SUD）の治療のインド市場規模（種類別、用途別）
・物質使用障害（SUD）の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・物質使用障害（SUD）の治療の世界市場予測（2019年-2025年）
・物質使用障害（SUD）の治療の地域別市場予測（2019年-2025年）
...

A substance use disorder (SUD), also known as a drug use disorder, is a medical condition in which the use of one or more substances leads to a clinically significant impairment or distress. Theres is habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of SUD. Some commonly used drug for treatment of SUD are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.In 2018, the global Substance Use Disorders (SUDs) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Substance Use Disorders (SUDs) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Substance Use Disorders (SUDs) Treatment development in United States, Europe and China.

The key players covered in this study
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy’s Laboratories
Teva Pharmaceutical

Market segment by Type, the product can be split into
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence

Market segment by Application, split into
Hospital & Clinics
Residential (non-hospital)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Substance Use Disorders (SUDs) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Substance Use Disorders (SUDs) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Substance Use Disorders (SUDs) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Substance Use Disorders (SUDs) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Opioid Addiction
1.4.3 Tobacco/Nicotine Addiction
1.4.4 Alcohol Dependence
1.5 Market by Application
1.5.1 Global Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2025)
1.5.2 Hospital & Clinics
1.5.3 Residential (non-hospital)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Substance Use Disorders (SUDs) Treatment Market Size
2.2 Substance Use Disorders (SUDs) Treatment Growth Trends by Regions
2.2.1 Substance Use Disorders (SUDs) Treatment Market Size by Regions (2014-2025)
2.2.2 Substance Use Disorders (SUDs) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Substance Use Disorders (SUDs) Treatment Market Size by Manufacturers
3.1.1 Global Substance Use Disorders (SUDs) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Substance Use Disorders (SUDs) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Substance Use Disorders (SUDs) Treatment Key Players Head office and Area Served
3.3 Key Players Substance Use Disorders (SUDs) Treatment Product/Solution/Service
3.4 Date of Enter into Substance Use Disorders (SUDs) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019)
4.2 Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
5.2 Substance Use Disorders (SUDs) Treatment Key Players in United States
5.3 United States Substance Use Disorders (SUDs) Treatment Market Size by Type
5.4 United States Substance Use Disorders (SUDs) Treatment Market Size by Application

6 Europe
6.1 Europe Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
6.2 Substance Use Disorders (SUDs) Treatment Key Players in Europe
6.3 Europe Substance Use Disorders (SUDs) Treatment Market Size by Type
6.4 Europe Substance Use Disorders (SUDs) Treatment Market Size by Application

7 China
7.1 China Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
7.2 Substance Use Disorders (SUDs) Treatment Key Players in China
7.3 China Substance Use Disorders (SUDs) Treatment Market Size by Type
7.4 China Substance Use Disorders (SUDs) Treatment Market Size by Application

8 Japan
8.1 Japan Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
8.2 Substance Use Disorders (SUDs) Treatment Key Players in Japan
8.3 Japan Substance Use Disorders (SUDs) Treatment Market Size by Type
8.4 Japan Substance Use Disorders (SUDs) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
9.2 Substance Use Disorders (SUDs) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Type
9.4 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Application

10 India
10.1 India Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
10.2 Substance Use Disorders (SUDs) Treatment Key Players in India
10.3 India Substance Use Disorders (SUDs) Treatment Market Size by Type
10.4 India Substance Use Disorders (SUDs) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
11.2 Substance Use Disorders (SUDs) Treatment Key Players in Central & South America
11.3 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Type
11.4 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Application

12 International Players Profiles
12.1 Indivior
12.1.1 Indivior Company Details
12.1.2 Company Description and Business Overview
12.1.3 Substance Use Disorders (SUDs) Treatment Introduction
12.1.4 Indivior Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.1.5 Indivior Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Substance Use Disorders (SUDs) Treatment Introduction
12.2.4 Pfizer Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Alkermes
12.3.1 Alkermes Company Details
12.3.2 Company Description and Business Overview
12.3.3 Substance Use Disorders (SUDs) Treatment Introduction
12.3.4 Alkermes Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.3.5 Alkermes Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Substance Use Disorders (SUDs) Treatment Introduction
12.4.4 Novartis Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Substance Use Disorders (SUDs) Treatment Introduction
12.5.4 Mylan Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.5.5 Mylan Recent Development
12.6 Cipla
12.6.1 Cipla Company Details
12.6.2 Company Description and Business Overview
12.6.3 Substance Use Disorders (SUDs) Treatment Introduction
12.6.4 Cipla Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.6.5 Cipla Recent Development
12.7 Glenmark
12.7.1 Glenmark Company Details
12.7.2 Company Description and Business Overview
12.7.3 Substance Use Disorders (SUDs) Treatment Introduction
12.7.4 Glenmark Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.7.5 Glenmark Recent Development
12.8 Dr. Reddy’s Laboratories
12.8.1 Dr. Reddy’s Laboratories Company Details
12.8.2 Company Description and Business Overview
12.8.3 Substance Use Disorders (SUDs) Treatment Introduction
12.8.4 Dr. Reddy’s Laboratories Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.8.5 Dr. Reddy’s Laboratories Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Substance Use Disorders (SUDs) Treatment Introduction
12.9.4 Teva Pharmaceutical Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
12.9.5 Teva Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Substance Use Disorders (SUDs) Treatment Key Market Segments
Table Key Players Substance Use Disorders (SUDs) Treatment Covered
Table Global Substance Use Disorders (SUDs) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size Market Share by Type 2014-2025
Figure Opioid Addiction Figures
Table Key Players of Opioid Addiction
Figure Tobacco/Nicotine Addiction Figures
Table Key Players of Tobacco/Nicotine Addiction
Figure Alcohol Dependence Figures
Table Key Players of Alcohol Dependence
Table Global Substance Use Disorders (SUDs) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital & Clinics Case Studies
Figure Residential (non-hospital) Case Studies
Figure Substance Use Disorders (SUDs) Treatment Report Years Considered
Table Global Substance Use Disorders (SUDs) Treatment Market Size 2014-2025 (Million US$)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Substance Use Disorders (SUDs) Treatment Market Share by Regions 2014-2019
Figure Global Substance Use Disorders (SUDs) Treatment Market Share by Regions 2014-2019
Figure Global Substance Use Disorders (SUDs) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Substance Use Disorders (SUDs) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Substance Use Disorders (SUDs) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Market Share by Manufacturers in 2018
Table Global Substance Use Disorders (SUDs) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Substance Use Disorders (SUDs) Treatment Product/Solution/Service
Table Date of Enter into Substance Use Disorders (SUDs) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Substance Use Disorders (SUDs) Treatment Market Size Share by Type (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size Market Share by Type (2014-2019)
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Substance Use Disorders (SUDs) Treatment Market Size Share by Application (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Application in 2018
Figure United States Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table United States Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table United States Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Figure Europe Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table Europe Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table Europe Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Figure China Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table China Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table China Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Figure Japan Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table Japan Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table Japan Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Figure India Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table India Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table India Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Figure Central & South America Substance Use Disorders (SUDs) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Substance Use Disorders (SUDs) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Substance Use Disorders (SUDs) Treatment Market Share (2018-2019)
Table Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Substance Use Disorders (SUDs) Treatment Market Share by Type (2014-2019)
Table Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2019)
Table Indivior Company Details
Table Indivior Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019) (Million US$)
Figure Indivior Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Indivior Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Alkermes Company Details
Table Alkermes Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Alkermes Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Alkermes Recent Development
Table Novartis Company Details
Table Novartis Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Novartis Recent Development
Table Mylan Company Details
Table Mylan Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Mylan Recent Development
Table Cipla Company Details
Table Cipla Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Cipla Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Cipla Recent Development
Table Glenmark Company Details
Table Glenmark Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Glenmark Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Glenmark Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Dr. Reddy's Laboratories Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Dr. Reddy's Laboratories Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Substance Use Disorders (SUDs) Treatment Market Size Share by Regions (2019-2025)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size Share by Regions in 2025
Figure United States Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Substance Use Disorders (SUDs) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size by Product (2019-2025)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size by Product in 2025
Table Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2019-2025)
Figure Global Substance Use Disorders (SUDs) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の性感染症（STD）の治療市場：市場規模・現状・予測

Global Sexually Transmitted Diseases (STD) Treatment Market Size, Status and Forecast 2019-2025
QYR9N8027 2019年6月14日 97Pages
当資料は、性感染症（STD）の治療のグローバル市場について調査・分析したレポートで、種類別（ウイルス感染、細菌感染、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の炎症性腸疾患（IBD）の治療市場：市場規模・現状・予測

Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7362 2019年6月14日 98Pages
当資料は、炎症性腸疾患（IBD）の治療のグローバル市場について調査・分析したレポートで、種類別（TNF阻害剤、アミノサリチル酸、免疫調節剤、コルチコステロイド）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予...

世界の姿勢起立性頻脈症候群（POTS）の治療市場：市場規模・現状・予測

Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7871 2019年6月14日 92Pages
当資料は、姿勢起立性頻脈症候群（POTS）の治療のグローバル市場について調査・分析したレポートで、種類別（一次フォーム、二次フォーム）、用途別（病院、診療所、外来手術センター、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...

世界の巣状分節性糸球体硬化症（FSGS）の治療市場：市場規模・現状・予測

Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7216 2019年6月14日 92Pages
当資料は、巣状分節性糸球体硬化症（FSGS）の治療のグローバル市場について調査・分析したレポートで、種類別（薬物療法、透析、腎臓移植）、用途別（一次FSGS、二次FSGS）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれていま...

世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測

Global Lysosomal Acid Lipase Deficiency (LAAL) Treatment Market Size, Status and Forecast 2019-2025
QYR9N7488 2019年6月14日 97Pages
当資料は、リソソーム酸リパーゼ欠乏症（LAAL）の治療のグローバル市場について調査・分析したレポートで、種類別（酵素補充療法、腎臓移植、幹細胞移植）、用途別（ウォルマン病、コレステロールエステル蓄積症（CESD））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...

世界の精神神経疾患および治療市場：市場規模・現状・予測

Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2019-2025
QYR9N7660 2019年6月14日 97Pages
当資料は、精神神経疾患および治療のグローバル市場について調査・分析したレポートで、種類別（変性疾患、神経障害、精神病）、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の前頭側頭障害の治療市場：市場規模・現状・予測

Global Frontotemporal Disorders Treatment Market Size, Status and Forecast 2019-2025
QYR9N7223 2019年6月14日 94Pages
当資料は、前頭側頭障害の治療のグローバル市場について調査・分析したレポートで、種類別（認知増強、抗精神病薬、抗うつ薬、中枢神経系覚醒剤、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報...

世界のライフサイエンス規制物質発注システム市場：市場規模・現状・予測

Global Life Sciences Controlled Substance Ordering System Market Size, Status and Forecast 2019-2025
QYR9N7453 2019年6月14日 99Pages
当資料は、ライフサイエンス規制物質発注システムのグローバル市場について調査・分析したレポートで、種類別（集中システム、クラウドベースのシステム、その他）、用途別（サービス提供者、個人バイヤー）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...

薬物乱用治療剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別

Global Substance Abuse Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR05A295 2019年5月26日 135Pages
当調査レポートでは、薬物乱用治療剤の世界市場について調査・分析し、薬物乱用治療剤の世界市場概観、メーカー動向、メーカー別薬物乱用治療剤シェア、市場規模推移、市場規模予測、薬物乱用治療剤種類別分析（アルコール乱用治療、ニコチン乱用治療、薬物乱用治療）、薬物乱用治療剤用途別分析（Hospitals、Cl...

世界の膝・股関節障害市場：市場規模・現状・予測

Global Knee & Hip Disorders Market Size, Status and Forecast 2019-2025
QYR9N7426 2019年6月14日 94Pages
当資料は、膝・股関節障害のグローバル市場について調査・分析したレポートで、種類別（股関節障害と治療、膝の障害と治療）、用途別（病院、外来手術センター、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の薬物中毒治療市場：市場規模・現状・予測 Drug addiction is a complex neurobiological disease that requires integrated treatment of the mind, body, and spirit. It is considered a brain disease because drugs change the brain — they change its structure and how it works. Without treatment, these brain changes can be long-lasting. Addiction is…
薬物乱用治療剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Substance Abuse Treatment is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Substance Abuse Treatme…
世界の薬物乱用治療市場：市場規模・現状・予測 Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for t…
世界の前頭側頭障害の治療市場：市場規模・現状・予測 In 2018, the global Frontotemporal Disorders Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Frontotemporal Disorders Treatment status, future forecast, growth opportunity, …
世界の精神神経疾患および治療市場：市場規模・現状・予測 Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…